Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
12.60
-0.44 (-3.37%)
Nov 22, 2024, 4:00 PM EST - Market closed
Evolus Revenue
Evolus had revenue of $61.09M in the quarter ending September 30, 2024, with 22.12% growth. This brings the company's revenue in the last twelve months to $248.33M, up 34.43% year-over-year. In the year 2023, Evolus had annual revenue of $202.09M with 35.98% growth.
Revenue (ttm)
$248.33M
Revenue Growth
+34.43%
P/S Ratio
3.07
Revenue / Employee
$909,619
Employees
273
Market Cap
797.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Services Group | 1.70B |
Embecta | 1.12B |
Castle Biosciences | 311.88M |
Paragon 28 | 245.00M |
Cytek Biosciences | 201.21M |
Capricor Therapeutics | 23.23M |
Liquidia | 15.61M |
EOLS News
- 16 days ago - Evolus, Inc. (EOLS) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 16 days ago - Evolus Reports Third Quarter 2024 Results - Business Wire
- 21 days ago - Evolus to Participate in Stifel 2024 Healthcare Conference - Business Wire
- 22 days ago - Evolus Announces EU Approval of Estyme® Injectable Hyaluronic Acid Gels Under New Medical Device Regulation - Business Wire
- 24 days ago - Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers - Business Wire
- 4 weeks ago - Evolus to Report Third Quarter Financial Results on November 6, 2024 - Business Wire
- 6 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 - Business Wire